Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden
一项在挪威和瑞典开展的随机对照试验（PRO-GLIO），旨在研究质子疗法与光子疗法治疗IDH突变型弥漫性2级和3级胶质瘤的生存率、生活质量和认知功能。
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2022-070071
Heggebø, Liv Cathrine; Borgen, Ida Maria Henriksen; Rylander, Hillevi; Kiserud, Cecilie; Nordenmark, Tonje Haug; Hellebust, Taran Paulsen; Evensen, Morten Egeberg; Gustavsson, Magnus; Ramberg, Christina; Sprauten, Mette; Magelssen, Henriette; Blakstad, Hanne; Moorthy, Janani; Andersson, Karin; Raunert, Ingela; Henry, Thomas; Moe, Cecilie; Granlund, Carin; Goplen, Dorota; Brekke, Jorunn; Johannessen, Tor-Christian Aase; Solheim, Tora Skeidsvoll; Marienhagen, Kirsten; Humberset, Øyvind; Bergström, Per; Agrup, Måns; Dahl, Ludvig; Gubanski, Michael; Gojon, Helene; Brahme, Carl-Johan; Rydén, Isabelle; Jakola, Asgeir S; Vik-Mo, Einar O; Lie, Hanne C; Asphaug, Lars; Hervani, Maziar; Kristensen, Ingrid; Rueegg, Corina Silvia; Olsen, Inge C; Ledal, Rolf J; Degsell, Eskil; Werlenius, Katja; Blomstrand, Malin; Brandal, Petter
